One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

A. A.M. van der Veldt; S. F. Oosting; R. S.N. Fehrmann; C. H. GeurtsvanKessel; R. S. van Binnendijk; A. M.C. Dingemans; E. F. Smit; T. J.N. Hiltermann; G. den Hartog; M. Jalving; T. T. Westphal; A. Bhattacharya; F. de Wilt; S. M. Ernst; A. Boerma; L. van Zijl; G. F. Rimmelzwaan; P. Kvistborg; C. A.C.M. van Els; N. Y. Rots; D. van Baarle; J. B.A.G. Haanen; E. G.E. de Vries

ArticleOPEN ACCESS

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

ESMO Open

DOI: 10.1016/j.esmoop.2023.100785

2Citations

6Readers

Cite

CITATION STYLE

APA

van der Veldt, A. A. M., Oosting, S. F., Fehrmann, R. S. N., GeurtsvanKessel, C. H., van Binnendijk, R. S., Dingemans, A. M. C., … de Vries, E. G. E. (2023, February 1). One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment. ESMO Open. Elsevier B.V. https://doi.org/10.1016/j.esmoop.2023.100785

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

Cite

Register to see more suggestions